Solution structure of amyloid β-peptide (25-35) in different media

被引:115
|
作者
D'Ursi, AM
Armenante, MR
Guerrini, R
Salvadori, S
Sorrentino, G
Picone, D
机构
[1] Univ Naples Federico II, Dipartimento Chim, I-80126 Naples, Italy
[2] Univ Naples Parthenope, I-80133 Naples, Italy
[3] Univ Ferrara, Dipartimento Sci Farmaceut, I-44100 Ferrara, Italy
[4] Univ Salerno, Dipartimento Sci Farmaceut, I-84084 Fisciano, Italy
关键词
D O I
10.1021/jm040773o
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The design of molecules able to interact with the amyloid peptides either as inhibitors of fibril formation or as inhibitors of amyloid membrane pore formation represents one of the most relevant approaches in the development of anti-Alzheimer therapies. Abeta-(25-35), sequence GSNKGAIIGLM, is a highly toxic synthetic derivative of amyloid beta-peptides (Abeta-peptides), which forms fibrillary aggregates. Here, we report the NMR and CD investigation of A,beta-(2535) in a membrane-mimicking environment and in isotropic mixtures of water and fluoroalcohols to scan its conformational properties as a function of the medium. The analysis of the 3D structures in the mentioned conditions indicates a propensity of the peptide to behave as a typical transmembrane helix in the lipidic environment. In media characterized by different polarity, it loses the structural regularity at specific points of the sequence as a function of the environment. Furthermore, a comparison with the solution structure of full-length amyloid peptides suggests a role for the 25-27 kink region, which appears to be a general feature of all peptides under the solution conditions explored.
引用
收藏
页码:4231 / 4238
页数:8
相关论文
共 50 条
  • [31] Potentiation of beta-folding of β-amyloid peptide 25-35 by aluminum salts
    Bondy, SC
    Truong, A
    NEUROSCIENCE LETTERS, 1999, 267 (01) : 25 - 28
  • [32] Amyloid β-peptide(25-35) changes [Ca2+] in hippocampal neurons
    Mogensen, HS
    Beatty, DM
    Morris, SJ
    Jorgensen, OS
    NEUROREPORT, 1998, 9 (07) : 1553 - 1558
  • [33] Genistein ameliorates β-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis
    Zeng, HY
    Chen, Q
    Zhao, BL
    FREE RADICAL BIOLOGY AND MEDICINE, 2004, 36 (02) : 180 - 188
  • [34] Effects of baicalein on β-amyloid peptide-(25-35)-induced amnesia in mice
    Wang, SY
    Wang, HH
    Chi, CW
    Chen, CF
    Liao, JF
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 506 (01) : 55 - 61
  • [35] Genistein ameliorated β-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis
    Zhao, BL
    NEUROBIOLOGY OF AGING, 2004, 25 : S569 - S569
  • [36] Amyloid Beta-Peptide 25-35 (Aβ25-35) Induces Cytotoxicity via Multiple Mechanisms: Roles of the Inhibition of Glucosylceramide Synthase by Aβ25-35 and Its Protection by D609
    Tang, Zhihui
    Motoyoshi, Kaisei
    Honda, Takuya
    Nakamura, Hiroyuki
    Murayama, Toshihiko
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021, 44 (10) : 1419 - 1426
  • [37] Transferrin neutralization of amyloid β 25-35 cytotoxicity
    Giunta, S
    Galeazzi, R
    Valli, MB
    Corder, EH
    Galeazzi, L
    CLINICA CHIMICA ACTA, 2004, 350 (1-2) : 129 - 136
  • [38] Effect of Cilostazol on Learning and Memory Impairment Induced by β Amyloid Peptide (25-35) in Mice
    Takiguchi, Osanao
    Mori, Hiromasa
    Nishiyama, Aki
    Nabeshima, Toshitaka
    Hiramatsu, Masayuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 88P - 88P
  • [39] Inhibition of toxicity in the β-amyloid peptide β(25-35) using N-methylated derivatives
    Doig, A
    Hughes, E
    Burke, R
    Lu, J
    Su, TJ
    Heenan, R
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S107 - S108
  • [40] Effect of beta-Amyloid Peptide Fragment 25-35 on Nonselective Permeability of Mitochondria
    E. F. Shevtzova
    E. G. Kireeva
    S. O. Bachurin
    Bulletin of Experimental Biology and Medicine, 2001, 132 : 1173 - 1176